Hospital Angeles Tijuana is a skyscraper and prominent fixture in Tijuana, Mexico. It serves as the primary hospital of Tijuana.

During the past decade, Hospital Angeles conducted 2 clinical trials. In the 10-year time frame, 2 clinical trials started and 0 clinical trials were completed, i.e. on average, 0% percent of trials that started reached the finish line to date. In the past 5 years, 1 clinical trials started and 0 clinical trials were completed. i.e. 0% of trials that started reached the finish line.

In terms of collaborators to trials, out of the total clinical trials conducted in "Hospital Angeles" #1 collaborator was "Instituto de Medicina Regenerativa" with 3 trials as a collaborator. Other collaborators include -1 different institutions and companies that were collaborators in the rest 1 trials.

According to Clinical.Site data, the most researched conditions in "Hospital Angeles" are "Brain Lesion (General)" (1 trials), "Breast Neoplasms" (1 trials), "Renal Failure" (1 trials) and "Stroke" (1 trials). Many other conditions were trialed in "Hospital Angeles" in a lesser frequency.

Most popular intervention types in "Hospital Angeles" are "Procedure" (3 trials) and "Drug" (1 trials). Other intervention types were less common.

The name of intervention was led by "Anastrozole" (1 trials), "Exemestane" (1 trials), "Harvesting and Isolation of Stem Cells" (1 trials), "Harvesting and Isolation of Stem cells" (1 trials) and "Imlunestrant" (1 trials). Other intervention names were less common.

The vast majority of trials in "Hospital Angeles" are 4 trials for "All" genders.

Currently, there are NaN active trials in "Hospital Angeles". undefined are not yet recruiting, 1 are recruiting, undefined are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were undefined completed trials in Hospital Angeles, undefined suspended trials, and undefined terminated clinical trials to date.

Out of the total trials that were conducted in Hospital Angeles, 1 "Phase 1" clinical trials were conducted, 1 "Phase 2" clinical trials and 1 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 0 trials, and there were also 2 trials that are defined as “Not Applicable".